KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Pension (2016 - 2025)

Astrazeneca (AZN) has 3 years of Pension data on record, last reported at $1.1 billion in Q4 2025.

  • For Q4 2025, Pension fell 16.92% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, down 16.92%, while the annual FY2025 figure was $1.1 billion, 16.92% down from the prior year.
  • Pension reached $1.1 billion in Q4 2025 per AZN's latest filing, down from $1.3 billion in the prior quarter.
  • Across five years, Pension topped out at $1.5 billion in Q4 2023 and bottomed at $1.1 billion in Q4 2025.
  • Average Pension over 3 years is $1.3 billion, with a median of $1.3 billion recorded in 2024.
  • Peak YoY movement for Pension: dropped 12.5% in 2024, then decreased 16.92% in 2025.
  • A 3-year view of Pension shows it stood at $1.5 billion in 2023, then decreased by 12.5% to $1.3 billion in 2024, then fell by 16.92% to $1.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Pension were $1.1 billion in Q4 2025, $1.3 billion in Q4 2024, and $1.5 billion in Q4 2023.